Table 1.
ID | Age/Sex | Smoking/drinking* | Major co-morbidities | Presenting symptom(s) | Family history | Prior cancer | Stage at diagnosis | Histology | Primary treatment | OS (m) | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 67/M | Y/N | Coronary artery disease, myocardial infarction | Dysuria | Prostate cancer in brother and cousin | No | II | Pure small cell | Radical surgery | 84 | Alive |
2 | 80/F | Y/N | Hypertension | Frequency, dysuria, Hematuria | No | No | II after neoadjuvant therapy | Small cell and high grade urothelial carcinoma | Neoadjuvant 4 cycle of Ca/E, then radical surgery | 48 | Dead |
3 | 62/M | Y/Y | Depression | Hematuria | No | No | II | Small cell and high grade papillary urothelial carcinoma | NA | 36 | Alive |
4 | 85/F | N/N | Stroke, myocardial infarction, hypertension, dementia | Renal failure | Colon cancer in son | Breast cancer | II | Pure Lc NEc# | TURBT then concurrent chemoradiation | 36 | Dead |
5 | 80/M | Y/N | Coronary artery disease, diabetes, hypertension, hypothyroidism | Difficulty in urination | Lung cancer in mother | No | II | Primary Lc NEc,# papillary urothelial carcinoma | Radical surgery | 25 | Dead |
6 | 70/M | Y/Y | Depression | Diagnosed on surveillance cystoscopy | None | TCCb, prostate cancer | II | Pure Lc NEc | Neoadjuvant 3 cycles of Ci/G, then radical surgery then 1 cycle of Ci/G | 17 | Alive |
7° | 78/F | Y/N | Coronary artery disease, myocardial infarction, atrial fibrillation, hypertension, hypothyroidism, depression | Hematuria | Breast cancer in 2 daughters | No | II | Pure small cell | Concurrent chemoradiation | 7 | Dead |
8 | 84/F | N/N | Hypertension, hypothyroidism | Hematuria | Lung in father | Breast | III | Small cell and squamous differentiation | Radical surgery | 108 | Alive |
9 | 69/M | Y/N | Hypertension | Hematuria | Kidney in father | No | III | Small cell and high grade urothelial carcinoma | Radical surgery | 26 | Dead |
10 | 55/F | Y/N | None | Left neck mass | Cancer in brother | No | IV | Small cell in primary and large cell neuroendocrine carcinoma in metastasis | Neoadjuvant 5 cycles of Ci/E, then radical surgery, then adjuvant 2 cycles of Ci/E | 30 | Dead |
11 | 89/M | Y/N | Dementia | Hematuria | No | No | IV | Small cell and adenocarcinoma | Partial cystectomy | 12 | Dead |
12 | 69/M | Y/N | Diabetes | Back pain | Gastric in mother | No | IV | Small cell and Lc NEc | 4 cycle of Ca/E, then radiation | 10 | Dead |
13 | 67/F | N/N | Congestive heart failure, diabetes, hypothyroidism | Hematuria/frequency, then pain | Unknown Cancer in mother; prostate cancer in brother | No | IV | Pure small cell | Chemotherapy, then RT which was prematurely stopped | 8 | Dead |
14 | 36/F | Y/N | Asthma | Hematuria | Lung cancer in father and grandmother; leukemia in aunt | No | IV | Pure Lc NEc# | Radical surgery, then Ci/E | 8 | Dead |
15 | 77/M | Y/N | Coronary artery disease, atrial fibrillation, hypertension, aortic aneurysm | Hematuria | No | No | IV | Small cell bladder carcinoma and prostate adenocarcinoma | Radical surgery | 7 | Dead |
16 | 78/F | N/N | Hypertension | Urgency, frequency | No | No | IV | Small cell and non-papillary urothelial carcinoma | Radical surgery | 6 | Dead |
17 | 78/F | Y/N | Hypertension, hypothyroidism, transient ischemic attack | Hematuria | Gastric in mother | No | IV | Pure small cell | Radical surgery | 5 | Dead |
18 | 84/F | Y/N | Depression and hypertension | Hematuria | No | Rectal | IV | Small cell and urothelial carcinoma in situl cycle of chemo, then hospice | 2 | Dead |
OS, overall survival; Ca/E, Carboplatin/Etoposide chemotherapy; yr, Year; m, Month; Lc NEc, Large cell neuroendocrine carcinoma; TURBT, Transurethral resection of bladder tumor; TCCb, transitional cell carcinoma of bladder; Ci/G, Cisplatin/Gemcitabine chemotherapy; Ci/E, Cisplatin/Etoposide chemotherapy; NA not available.
*Smoking status was defined as no for never-smoker and yes for ever-smoker. Social drinking was considered as no drinking.
°Cancer cells showed multiple copies of chromosomes 3, 7 and 17.
#The primary cancer in these patients was large cell neuroendocrine carcinoma.